Altium Limited

ALU

Altium Ltd. engages in the development and sale of computer software for the design of electronic products. The company is headquartered in Chatswood, New South Wales. The firm is engaged in the development and sales of computer software for the design of electronic products. The company focuses on electronics design systems for 3D printed circuit board (PCB) design and embedded system development. The company operates through two segments: Board and Systems, and Nexar. Board and Systems segment includes results from the PCB business for the Americas, Europe, Middle East, Africa (EMEA), China and Asia- Pacific, Altium Nexus as well as other products sold through partner channels and the manufacturing business. The Company’s Nexar segment includes the results from Octopart, Upverter and other products sold through the manufacturing business. Its software tools and platforms include Altium Circuitmaker, Altium Circuitstudio, Upverter, Power Analyzer by Keysight, EE Concierge, Altimade, Octopart, and Nexar. Its enterprise solutions enable digital management of workflow processes and resources.

Alvo Minerals Limited

ALV

Alvo Minerals Ltd. explores and develops metals. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-10-20. The firm holds an interest in the Palmeiropolis Tenements. The Palmeiropolis Tenements, along with Alvo’s interest in nearby and adjacent exploration permits comprises the Company’s Palma Project. The Palma Project is a Copper/Zinc rich volcanogenic massive sulfide (VMS) belt in Central Brazil, which comprises approximately 500 square kilometers (km2) of granted exploration licenses. The two main prospects within the Palmeiropolis Tenements (C1 and C3) are the subject of an estimated inferred mineral resource. Alvo’s inferred mineral resource totals over 4,600,000 tons, primarily comprised of approximately 179,000 tons of zinc, 44,000 tons of copper and 3,000,000 ounces of silver. The Company’s subsidiaries include Perth Recursos Minerais Ltda (Perth Brazil) and Alvo Recursos Minerais SPE Eireli.

Als Limited

ALQ

ALS Ltd. engages in the analytical and testing services businesses and partnerships. The company is headquartered in Brisbane, Queensland and currently employs 18,500 full-time employees. The firm operates under three segments: Commodities, Life Sciences, and Industrial. Commodities segment provides assaying and analytical testing services and metallurgical services for mining and mineral exploration companies and provides specialist services to the coal industry, such as coal sampling, analysis and certification, formation evaluation services and related analytical testing. Life Sciences segment provides analytical testing data to assist consulting and engineering firms, industry, and governments in making informed decisions about environmental, food and pharmaceutical, electronics, and animal health testing matters. The industrial segment provides the energy, resources, transportation and infrastructure sectors with asset care and tribology testing services. The company offers services in asset integrity and reliability, environmental and occupational hygiene, mining, and pharmaceutical and healthcare.

Analytica Limited

ALT

Analytica Ltd. engages in the design development, and supply of class 1 and class 2 medical devices. The company is headquartered in Brisbane, Queensland. The company went IPO on 2000-10-25. Its lead product is the PeriCoach System- an e-health treatment system for women who suffer stress urinary incontinence. PeriCoach includes a device, Web portal and smartphone app and the device evaluates activity in pelvic floor muscles. This information is transmitted to a smartphone app and can be loaded to a cloud database where physicians can monitor patient progress via Web portal. The firm is also the developer of the Enhanced Infusion System (EIS), a combination of technologies developed under the project names AutoStart and AutoFlush. The company is also commercializing the AutoStart Burette infusion system. The EIS is a simple and inexpensive IV add-in technology to reduce nursing monitoring costs, reduce embolism risk, improve infection control and automatically restart flow after medication delivery during intravenous fluid infusion.